– ISRAEL, Yokne’am Illit – ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced the appointment of Dr. Fred Moll to its Board of Directors.
About Dr. Fred Moll
A distinguished and prolific medical device entrepreneur, Dr. Moll brings decades of expertise to the ForSight Board. He founded Intuitive Surgical in the 1990s, pioneering robotic-assisted surgery and transforming minimally invasive procedures across dozens of specialties with its da Vinci robotic system. He then founded Auris Health, which was acquired by Johnson & Johnson in 2019. Most recently, he served as CDO for J&J Medical Devices between 2019 and 2023. He has served on ForSight’s Strategic Advisory Board since the company’s founding in 2020 and is a current investor in ForSight Robotics.
“Throughout my career, I have worked with medical robotics companies to improve healthcare access and outcomes for patients worldwide,” said Dr. Fred Moll. “ForSight Robotics is advancing surgical robotics in eye care, helping to avoid preventable blindness and address the global shortage of ophthalmic surgeons. Having supported the company since its inception, I’m confident in its team, tools, and potential to reshape the industry. I’m proud to continue serving as a strategic advisor during this period of significant growth.”
About ForSight Robotics:
ForSight Robotics is a surgical robotics company pioneering world-class technology to democratize quality surgical eye care. The Israel-based company is developing the ORYOMTM Platform, the world’s first robotic surgery platform for cataracts and eye diseases, which will utilize AI-based algorithms, computer vision, and miniaturized mechanics. Backed by globally recognized VCs and industry leaders, ForSight is redefining ophthalmic surgery and bringing hope to millions of patients worldwide.
For more information: https://www.forsightrobotics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.